Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility

Summary by AI BETAClose X

Novonesis has successfully issued EUR 1.7 billion in senior unsecured notes under its new EUR 4 billion EMTN Program, with maturities ranging from 4 to 11 years and fixed interest rates between 3.25% and 4.00%. This issuance, rated A with a stable outlook, is primarily intended to refinance a bridge facility used for the acquisition of dsm-firmenich's stake in the Feed Enzyme Alliance, a move that grants Novonesis full control of the alliance's sales and distribution and strengthens its position in the animal biosolutions value chain.

Disclaimer*

UK 100

Latest directors dealings